| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 2571.9 | 2471.3 | 2048.6 |
| Other income | 1.8 | 0.5 | 0.1 |
| Total income | 2573.7 | 2471.8 | 2048.8 |
| Profit before exceptional items & tax | 181.5 | 183.7 | 81.7 |
| Profit before tax | 181.5 | 183.7 | 81.7 |
| Net profit | 135.6 | 137.8 | 60.5 |
| Operating margin | 7.1% | 7.4% | 4.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +124.10% |
|---|---|
| Net profit, quarter on quarter | -1.60% |
| Revenue, year on year | +25.50% |
NSE results filing, NSE: NIVABUPA. Figures extracted from the filing.
Niva Bupa Health Insurance Company Ltd: key numbers
- Share price
- ₹75.00
- Market cap
- ₹13,880 Cr
- Revenue (annual)
- ₹6,695 Cr
- Net profit (annual)
- ₹130.8 Cr
- P/E (TTM)
- 38.5×Sector 19.4×
- Promoter holding
- 55.29%-0.01% QoQ
- FII holding
- 12.95%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Niva Bupa Health Insurance Company Ltd
All →Niva Bupa Health Insurance Company Board Meeting Outcome
Niva Bupa Health Insurance Company's Board approved amendments and the consolidation of its PIT policies. The updated policy integrates UPSI fair disclosure and leak inquiry procedures into a single framework.
Niva Bupa Health Insurance Company Investor Presentation: Key Takeaways
H1 FY27 GWP ₹4,634 Cr (+33.4% y-o-y, 1/n basis); PAT ₹273.4 Cr, more than doubled; CISR improved to 99.5% from 103.1%; retail health share 11.0%.
Niva Bupa Health Insurance Company Other Announcement
Niva Bupa Health Insurance's Board approved the amendment and consolidation of its UPSI Fair Disclosure and Leak Inquiry policies. The integrated policy streamlines operational compliance under SEBI PIT Regulations.
Niva Bupa Health Insurance Company Employee Stock Options
Niva Bupa allotted 9,89,450 equity shares to employees on exercise of ESOP options under its 2020 and 2024 schemes. Paid-up capital rose to Rs. 18,50,63,41,530.
Niva Bupa Health Insurance Company Board Meeting Date
Niva Bupa will hold a board meeting on November 4, 2026 to consider unaudited results for the quarter and half-year ended September 30, 2026. The trading window stays closed until November 6, 2026.
Niva Bupa Health Insurance Company Management Change
Niva Bupa Health Insurance Company Limited announced the sad demise of Mr. Roger William John Davis, a Non-Executive Non-Independent Director, effective October 17, 2026.